Chou, Chia-An <br/><br/>
Rosiglitazone attenuates indoxyl sulphate-induced endothelial dysfunction.  [electronic resource] 

 -  Clinical and experimental pharmacology & physiology  Mar 2015 
 - 287-92 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1440-1681 
<br/><br/><label>Standard No.: </label>10.1111/1440-1681.12351  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Gene Expression Regulation--drug effects<br/>Human Umbilical Vein Endothelial Cells--cytology<br/>Humans<br/>Indican--toxicity<br/>MAP Kinase Signaling System--drug effects<br/>Mitogen-Activated Protein Kinases--metabolism<br/>NF-kappa B--metabolism<br/>Oxidative Stress--drug effects<br/>Rosiglitazone<br/>Thiazolidinediones--pharmacology